Company news

Exicure, Inc. news in 2020

Exicure, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Exicure Announces Webcast of Presentation at 2021 HC Wainwright BIOCONNECT Conference

December 28, 2020

Exicure Provides Neuroscience Pipeline Update at Virtual R&D Day

December 27, 2020

Exicure Announces Issuance of Two New U.S. Patents and A New Patent Allowance Covering Cavrotolimod Through 2034

December 20, 2020

Exicure to Participate in Upcoming Conferences

November 15, 2020

Exicure, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

November 11, 2020

Exicure, Inc. Reports Third Quarter 2020 Financial Results and Corporate Progress

November 11, 2020

Exicure Presents Positive Clinical Data with Cavrotolimod at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

November 8, 2020

Exicure Announces Phase 1b Poster Presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

October 18, 2020

Exicure to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

October 4, 2020

Exicure Secures Debt Facility for Up to $25.0 Million

September 30, 2020

Exicure Presents Promising Interim Results from Ongoing Phase 1b/2 Trial of Cavrotolimod at Virtual KOL Event Today

September 15, 2020

Exicure to Present at Upcoming Conferences

September 9, 2020

Exicure Announces a Virtual KOL Meeting to Discuss Preliminary Phase 1b Efficacy Data for Cavrotolimod

August 24, 2020

Exicure, Inc. Reports Second Quarter 2020 Financial Results and Corporate Progress

August 11, 2020

Exicure, Inc. Added to Russell 2000® Index

June 28, 2020

Exicure Announces First Patient Dosed in Phase 2 Merkel Cell Carcinoma Trial of Cavrotolimod (AST-008)

June 15, 2020

Exicure Announces Appointment of Dr. Douglas E. Feltner as Chief Medical Officer

May 18, 2020

Exicure, Inc. Reports First Quarter 2020 Financial Results and Corporate Progress

May 13, 2020

Exicure, Inc. Announces Appointment of Timothy P. Walbert as Chairman of the Board

April 6, 2020

Exicure Provides Business Update Amid COVID-19 Pandemic

March 29, 2020

Exicure, Inc. Reports Full Year 2019 Financial Results and Corporate Progress

March 2, 2020

Decks in 2020